These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 10048679)

  • 21. Application of serology and nested polymerase chain reaction for identifying
    Kumar S; Saigal SR; Sethi GR; Kumar S
    Indian J Pathol Microbiol; 2016; 59(4):499-503. PubMed ID: 27721281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Community-acquired pneumonia in children: importance of Mycoplasma pneumoniae infections and efficacy of antibiotics].
    Gendrel D; Raymond J; Moulin F; Iniguez JL; Truong M; Ravilly S; Chaussain M; Lebon P; Kalifa G
    Presse Med; 1996 May; 25(17):793-7. PubMed ID: 8762275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective surveillance for atypical pathogens in children with community-acquired pneumonia in Japan.
    Bamba M; Jozaki K; Sugaya N; Tamai S; Ishihara J; Kori T; Shiro H; Takeuchi Y; Cho H; Nakao A; Okano Y; Kimura K; Komiyama O; Nonoyama M; Kobayashi I; Kato T; Sunakawa K
    J Infect Chemother; 2006 Feb; 12(1):36-41. PubMed ID: 16506088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etiology of community-acquired pneumonia in hospitalized children in northern Taiwan.
    Chen CJ; Lin PY; Tsai MH; Huang CG; Tsao KC; Wong KS; Chang LY; Chiu CH; Lin TY; Huang YC
    Pediatr Infect Dis J; 2012 Nov; 31(11):e196-201. PubMed ID: 22935863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora.
    Cohen R; Navel M; Grunberg J; Boucherat M; Geslin P; Derriennic M; Pichon F; Goehrs JM
    Pediatr Infect Dis J; 1999 May; 18(5):403-9. PubMed ID: 10353511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial etiology of acute otitis media and clinical efficacy of amoxicillin-clavulanate versus azithromycin.
    Guven M; Bulut Y; Sezer T; Aladag I; Eyibilen A; Etikan I
    Int J Pediatr Otorhinolaryngol; 2006 May; 70(5):915-23. PubMed ID: 16293317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aetiology of community-acquired pneumonia: serological results of a paediatric survey.
    Don M; Fasoli L; Paldanius M; Vainionpää R; Kleemola M; Räty R; Leinonen M; Korppi M; Tenore A; Canciani M
    Scand J Infect Dis; 2005; 37(11-12):806-12. PubMed ID: 16308213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Culture versus polymerase chain reaction for the etiologic diagnosis of community-acquired pneumonia in antibiotic-pretreated pediatric patients.
    Deng J; Zheng Y; Zhao R; Wright PF; Stratton CW; Tang YW
    Pediatr Infect Dis J; 2009 Jan; 28(1):53-5. PubMed ID: 19034066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Etiology of community-acquired pneumonia in hospitalized patients in chile: the increasing prevalence of respiratory viruses among classic pathogens.
    Díaz A; Barria P; Niederman M; Restrepo MI; Dreyse J; Fuentes G; Couble B; Saldias F
    Chest; 2007 Mar; 131(3):779-787. PubMed ID: 17356093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community-acquired pneumonia in children.
    Sinaniotis CA; Sinaniotis AC
    Curr Opin Pulm Med; 2005 May; 11(3):218-25. PubMed ID: 15818183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Chlamydia pneumoniae.
    Hammerschlag MR
    Int J Antimicrob Agents; 2000 Aug; 15(3):239, 241. PubMed ID: 10926449
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
    Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
    Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection.
    Yanagihara K; Izumikawa K; Higa F; Tateyama M; Tokimatsu I; Hiramatsu K; Fujita J; Kadota J; Kohno S
    Intern Med; 2009; 48(7):527-35. PubMed ID: 19336954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and epidemiological characteristics in children with community-acquired mycoplasma pneumonia in Taiwan: A nationwide surveillance.
    Ma YJ; Wang SM; Cho YH; Shen CF; Liu CC; Chi H; Huang YC; Huang LM; Huang YC; Lin HC; Ho YH; Mu JJ;
    J Microbiol Immunol Infect; 2015 Dec; 48(6):632-8. PubMed ID: 25311405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial.
    Vergis EN; Indorf A; File TM; Phillips J; Bates J; Tan J; Sarosi GA; Grayston JT; Summersgill J; YU VL
    Arch Intern Med; 2000 May; 160(9):1294-300. PubMed ID: 10809032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlamydial pneumonia in children requiring hospitalization: effect of mixed infection on clinical outcome.
    Tsai MH; Huang YC; Chen CJ; Lin PY; Chang LY; Chiu CH; Tsao KC; Huang CG; Lin TY
    J Microbiol Immunol Infect; 2005 Apr; 38(2):117-22. PubMed ID: 15843856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [What is new in the treatment of community-acquired pneumonia?].
    Welte T; Marre R; Suttorp N;
    Med Klin (Munich); 2006 Apr; 101(4):313-20. PubMed ID: 16607488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison study between GeXP-based multiplex-PCR and serology assay for Mycoplasma pneumoniae detection in children with community acquired pneumonia.
    Wang L; Feng Z; Zhao M; Yang S; Yan X; Guo W; Shi Z; Li G
    BMC Infect Dis; 2017 Jul; 17(1):518. PubMed ID: 28743259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone.
    García Vázquez E; Mensa J; Martínez JA; Marcos MA; Puig J; Ortega M; Torres A
    Eur J Clin Microbiol Infect Dis; 2005 Mar; 24(3):190-5. PubMed ID: 15782278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies.
    Aubier M; Lode H; Gialdroni-Grassi G; Huchon G; Hosie J; Legakis N; Regamey C; Segev S; Vester R; Wijnands WJ; Tolstuchow N
    J Antimicrob Chemother; 1996 May; 37 Suppl A():73-82. PubMed ID: 8737127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.